Inogen Inc (INGN) Stock Price, Quote & News

Company Profile

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One and Inogen Rove, an ambulatory solutions for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Inogen At Home stationary oxygen concentrators;...

Industry: Medical Devices

Sector: Healthcare

Phone: 805 562 0500

Website: www.inogen.com

Address:

859 Ward Drive, Goleta, United States

ZacksResearch Jan. 2 at 3:03 PM

Inogen ($INGN) poised for growth despite 10.3% stock dip in 6 months against industry growth of 5.2%! 📉 ⚡️ Projected 37.8% earnings growth for 2026 🛠️ Expanding product portfolio, including new Simeox device 🌍 Strategic partnerships bolster international reach Discover the details here 👉 https://www.zacks.com/stock/news/2811239/heres-why-you-should-add-inogen-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2811239-body-27111&ADID=SYND_STOCKTWITS_TWEET_2_2811239_BODY_27111

0 · Reply

ZacksResearch Jan. 2 at 2:03 PM

$INGN is heating up — this might be the add investors are looking for. 🚀 Rising POC demand, new product launches, and strong Q3 sales are driving momentum, even as competition and forex swings temper near-term growth. See why Inogen could be worth adding now 👉 https://www.zacks.com/stock/news/2811239/heres-why-you-should-add-inogen-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2811239-teaser-27110&ADID=SYND_STOCKTWITS_TWEET_2_2811239_TEASER_27110

0 · Reply

BillionerOfKing Dec. 26 at 9:56 PM

$INGN Current Stock Price: $6.80 Contracts to trade: $7.5 INGN Jan 16 2026 Call Entry: $0.14 Exit: $0.26 ROI: 89% Hold ~24 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

TalkMarkets Dec. 25 at 9:27 PM

How To Find The Best Value Stock Screens For 2026 $RWT $INGN $VSTS https://talkmarkets.com/content/stocks--equities/how-to-find-the-best-value-stock-screens-for-2026?post=546725

0 · Reply

ZacksResearch Dec. 23 at 2:47 PM

How to Find the Best Value Stock Screens for 2026. $INGN https://www.zacks.com/stock/news/2807602/how-to-find-the-best-value-stock-screens-for-2026?cid=sm-stocktwits-1-2807602-title&ADID=SYND_STOCKTWITS_TWEET_1_2807602_TITLE

0 · Reply

SuperGreenToday Dec. 19 at 4:36 PM

$INGN Share Price: $6.74 Contract Selected: Jun 18, 2026 $7.5 Calls Buy Zone: $0.51 – $0.63 Target Zone: $0.87 – $1.06 Potential Upside: 61% ROI Time to Expiration: 180 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

zecca1889 Dec. 19 at 3:58 PM

$INGN but did we hibernate or did we die?

0 · Reply

ZacksResearch Dec. 19 at 1:47 PM

3 MedTech stocks set for a big 2026? 🚀 🏠 $AVAH: 92.3% surge in 6 months, Zacks Rank #2, expanding homecare services and partnerships 🩺 $INGN: 37.8% earnings growth expected, turnaround strategy gaining traction 🌐 $CCLD: Cloud-based solutions and AI innovation, earnings estimates up 23.5% Discover why these stocks could shine 👉 https://www.zacks.com/stock/news/2806617/3-medtech-innovators-shaping-healthcare-in-2026-avah-ingn-ccld?cid=sm-stocktwits-2-2806617-body-25564&ADID=SYND_STOCKTWITS_TWEET_2_2806617_BODY_25564

0 · Reply

ZacksResearch Dec. 19 at 12:47 PM

3 MedTech names quietly shaping healthcare into 2026 — are you watching these? 👀 $AVAH, $INGN & $CCLD highlight where care delivery is headed: home-based care, portable oxygen technology, and cloud healthcare IT driving efficiency and access into 2026. This isn’t hype — it’s a clear shift in how healthcare gets delivered and scaled. See the full breakdown on how these trends are coming together 👉 https://www.zacks.com/stock/news/2806617/3-medtech-innovators-shaping-healthcare-in-2026-avah-ingn-ccld?cid=sm-stocktwits-2-2806617-teaser-25563&ADID=SYND_STOCKTWITS_TWEET_2_2806617_TEASER_25563

0 · Reply

ZacksResearch Dec. 5 at 2:25 PM

$INGN down 23.8% in 2025, but is it a hidden gem? 🧐 🔋 Strong Q3 performance with a 4% increase in quarterly revenues 📈 Huge prospects in the POC space with a projected market growth to $3.03B by 2030 🤝 Strategic collaborations boosting international reach Discover why this Zacks Rank #2 stock could be poised for a rebound 👉 https://www.zacks.com/stock/news/2800164/heres-why-you-should-add-inogen-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2800164-body-23610&ADID=SYND_STOCKTWITS_TWEET_2_2800164_BODY_23610

0 · Reply

Slow Progress At Inogen

Nov 5, 2025, 5:01 PM EST - 2 months ago

Inogen, Inc. (INGN) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 7:30 AM EST - 2 months ago

Inogen Announces Third Quarter 2025 Financial Results

Oct 15, 2025, 8:30 AM EDT - 2 months ago

Inogen to Report Third Quarter 2025 Financial Results on November 5, 2025

Sep 25, 2025, 4:05 PM EDT - 3 months ago

Inogen Announces the Appointment of Naga Rameswamy as Chief Technology Officer

Aug 8, 2025, 6:18 PM EDT - 5 months ago

Inogen, Inc. (INGN) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 4:05 PM EDT - 5 months ago

Inogen Announces Second Quarter 2025 Financial Results

Jul 17, 2025, 8:30 AM EDT - 6 months ago

Inogen to Report Second Quarter 2025 Financial Results on August 7, 2025

Jun 23, 2025, 8:30 AM EDT - 7 months ago

Inogen Introduces Voxi 5 Stationary Oxygen Concentrator: Setting a New Standard in Affordable, Durable Oxygen Therapy

May 22, 2025, 1:38 PM EDT - 8 months ago

Inogen Upgraded: Analyst Sees Growth, EBITDA Breakthrough

May 7, 2025, 8:16 PM EDT - 8 months ago

Inogen, Inc. (INGN) Q1 2025 Earnings Call Transcript

May 7, 2025, 4:05 PM EDT - 8 months ago

Inogen Announces First Quarter 2025 Financial Results

Mar 20, 2025, 8:30 AM EDT - 10 months ago

Inogen To Present at 24th Annual Needham Virtual Healthcare Conference

Mar 1, 2025, 8:56 AM EST - 11 months ago

A Volatile Share Price Masks Some Of The Progress At Inogen

Feb 26, 2025, 4:21 PM EST - 11 months ago

What's Going On With MedTech Focused Inogen Stock On Wednesday?

Feb 25, 2025, 8:03 PM EST - 11 months ago

Inogen, Inc. (INGN) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 4:05 PM EST - 11 months ago

Inogen Announces Fourth Quarter and Full Year 2024 Financial Results

Feb 3, 2025, 4:00 PM EST - 1 year ago

Inogen Announces Appointment of Mira Kirti Sahney to Board of Directors and Retirement of Board Member Tom West

Jan 26, 2025, 10:17 PM EST - 1 year ago

Arab Health 2025｜Yuwell Medical Announces Strategic Investment and Partnership with Inogen in Respiratory Health

Jan 26, 2025, 12:00 PM EST - 1 year ago

Inogen Expands Product Portfolio, Global Reach and Innovation Pipeline Through Strategic Collaboration With Yuwell

Jan 13, 2025, 4:00 PM EST - 1 year ago

Inogen Announces Preliminary Fourth Quarter and Full Year 2024 Revenue

Dec 30, 2024, 8:30 AM EST - 1 year ago

Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device

Nov 9, 2024, 9:55 PM EST - 1 year ago

Inogen, Inc. (INGN) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 4:05 PM EST - 1 year ago

Inogen Announces Third Quarter 2024 Financial Results

Nov 4, 2024, 8:30 AM EST - 1 year ago

Inogen to Present at Upcoming Investor Conferences

Oct 17, 2024, 8:30 AM EDT - 1 year ago

Inogen to Report Third Quarter 2024 Financial Results on November 7, 2024

Oct 8, 2024, 8:30 AM EDT - 1 year ago

Inogen Launches Rove 4 Portable Oxygen Concentrator, Delivering the Highest Oxygen Output in the Lightest Weight 4-Setting POC

Sep 5, 2024, 8:30 AM EDT - 1 year ago

Inogen Appoints Eric Pauls as Vice President of Sales, North America

Aug 6, 2024, 9:11 PM EDT - 1 year ago

Inogen, Inc. (INGN) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 4:05 PM EDT - 1 year ago

Inogen Announces Second Quarter 2024 Financial Results

Jul 16, 2024, 8:30 AM EDT - 1 year ago

Inogen to Report Second Quarter 2024 Financial Results on August 6, 2024

Jul 3, 2024, 4:10 PM EDT - 1 year ago

Inogen Strengthens Leadership Team with Appointment of New General Counsel and Executive Vice President, Business Development

Jun 3, 2024, 4:05 PM EDT - 1 year ago

Inogen Announces Publication of Study Demonstrating the Association of Portable Oxygen Therapy with Decreased Mortality and Increased Cost-Effectiveness Ratio

May 7, 2024, 10:30 PM EDT - 1 year ago

Inogen, Inc. (INGN) Q1 2024 Earnings Call Transcript

May 7, 2024, 4:05 PM EDT - 1 year ago

Inogen Announces First Quarter 2024 Financial Results

Apr 10, 2024, 8:30 AM EDT - 1 year ago

Inogen to Report First Quarter 2024 Financial Results on May 7, 2024

Mar 25, 2024, 8:30 AM EDT - 1 year ago

Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference

Mar 7, 2024, 4:00 PM EST - 1 year ago

Inogen, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Feb 27, 2024, 7:09 PM EST - 2 years ago

Inogen, Inc. (INGN) Q4 2023 Earnings Call Transcript

Feb 27, 2024, 4:05 PM EST - 2 years ago

Inogen Announces Fourth Quarter and Full-Year 2023 Financial Results

Jan 30, 2024, 4:00 PM EST - 2 years ago

Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024

Jan 24, 2024, 4:00 PM EST - 2 years ago

Inogen Names Michael Bourque as New Chief Financial Officer

Jan 1, 2024, 8:47 AM EST - 2 years ago

Inogen: Time To Be Greedy When Others Are Fearful

Nov 9, 2023, 2:30 PM EST - 2 years ago

Inogen to Present at Upcoming Investor Conferences in November 2023

Nov 7, 2023, 11:08 PM EST - 2 years ago

Inogen, Inc. (INGN) Q3 2023 Earnings Call Transcript

Nov 7, 2023, 4:05 PM EST - 2 years ago

Inogen Announces Third Quarter 2023 Financial Results

Oct 10, 2023, 4:00 PM EDT - 2 years ago

Inogen to Report Third Quarter 2023 Financial Results on November 7, 2023

Sep 18, 2023, 8:30 AM EDT - 2 years ago

Inogen Completes Acquisition of Physio-Assist

Sep 7, 2023, 8:30 AM EDT - 2 years ago

Inogen Announces CFO Transition Plan

Aug 8, 2023, 8:30 AM EDT - 2 years ago

Inogen Recognized as a Finalist for Ragan's CSR & Diversity Awards Program

ZacksResearch Jan. 2 at 3:03 PM

0 · Reply

ZacksResearch Jan. 2 at 2:03 PM

0 · Reply

BillionerOfKing Dec. 26 at 9:56 PM

0 · Reply

TalkMarkets Dec. 25 at 9:27 PM

How To Find The Best Value Stock Screens For 2026 $RWT $INGN $VSTS https://talkmarkets.com/content/stocks--equities/how-to-find-the-best-value-stock-screens-for-2026?post=546725

0 · Reply

ZacksResearch Dec. 23 at 2:47 PM

0 · Reply

SuperGreenToday Dec. 19 at 4:36 PM

0 · Reply

zecca1889 Dec. 19 at 3:58 PM

$INGN but did we hibernate or did we die?

0 · Reply

ZacksResearch Dec. 19 at 1:47 PM

0 · Reply

ZacksResearch Dec. 19 at 12:47 PM

0 · Reply

ZacksResearch Dec. 5 at 2:25 PM

0 · Reply

ZacksResearch Dec. 5 at 1:05 PM

$INGN is quietly building real momentum — and the setup is getting hard to ignore. Rising POC demand, fresh product launches, and strong Q3 sales are pushing the story forward, even as competition and forex swings temper near-term growth. Full breakdown here 👉 https://www.zacks.com/stock/news/2800164/heres-why-you-should-add-inogen-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2800164-teaser-23569&ADID=SYND_STOCKTWITS_TWEET_2_2800164_TEASER_23569

0 · Reply

Estimize Dec. 3 at 11:00 AM

Wall St is expecting -0.18 EPS for $INGN Q4 [Reporting 03/03 BMO] http://www.estimize.com/intro/ingn?chart=historical&metric_name=eps&utm_c

0 · Reply

RunnerSignals Nov. 15 at 4:53 PM

$COIN $EVGO $INGN $KAI $LW oversold and ready for a rebound or more pain? The charts are talking, are you listening? https://stocksrunner.com/news/2025-11-15-daily-market-pulse-advanced-technical-analysis

0 · Reply

SuperGreenToday Nov. 13 at 9:50 PM

$INGN Share Price: $6.89 Contract Selected: Jun 18, 2026 $7.5 Calls Buy Zone: $0.04 – $0.05 Target Zone: $0.07 – $0.08 Potential Upside: 50% ROI Time to Expiration: 216 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

ZacksResearch Nov. 6 at 7:59 PM

$INGN's loss narrows but shares plunge 8.3% — what's going on? 🤔 📉 Missed revenue estimate despite 4% YoY growth ⚠️ Decline in domestic direct-to-consumer and rental revenues 💡 New product launches show promise, but challenges remain Understand the risks before investing in INGN 👉 https://www.zacks.com/stock/news/2787146/inogen-stock-dips-despite-q3-earnings-beat-revenues-up-yy?cid=sm-stocktwits-2-2787146-body-19956&ADID=SYND_STOCKTWITS_TWEET_2_2787146_BODY_19956

0 · Reply

ZacksResearch Nov. 6 at 6:59 PM

$INGN beats Q3 earnings — but investors aren’t buying it. A narrower loss and stronger B2B demand couldn’t offset softness in consumer and rental sales, pushing the stock lower. Full results breakdown here 👉 https://www.zacks.com/stock/news/2787146/inogen-stock-dips-despite-q3-earnings-beat-revenues-up-yy?cid=sm-stocktwits-2-2787146-teaser-19945&ADID=SYND_STOCKTWITS_TWEET_2_2787146_TEASER_19945

0 · Reply

kaefer Nov. 5 at 12:49 PM

$INGN reports earnings https://www.businesswire.com/news/home/20251105832834/en

0 · Reply

BillionerOfKing Nov. 4 at 4:18 PM

$INGN Current Stock Price: $8.14 Contracts to trade: $10 INGN Nov 21 2025 Call Entry: $0.36 Exit: $0.48 ROI: 34% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

Pnmoltke Oct. 15 at 2:28 PM

$INGN $INGN have approx. 700 employees today so its basically 5-6% of the workforce they are suddenly having as new job hires (40 in total). Half of it alone here in October. A reason behind this relatively many hires could be that growth are finally picking up for Inogen. I look forward to their Q3 on November 5th.

0 · Reply

Pnmoltke Oct. 13 at 12:56 PM

$INGN Number of jobs adds increasing rapidly! 6-9 month ago there was only 10-12 jobs adds on Inogens site. Now there is almost 40 and half of it are new ones from October 2025. Is growth picking up with the launch of Voxi 5 i july amonst others?

0 · Reply

assisi Oct. 7 at 5:00 PM

@sogenerous apologies for putting another non AI or tech name on the radar but $INGN potentially worth a look

0 · Reply

quantMoth Oct. 5 at 7:49 AM

$INGN Genomic medicine focus. Testing breakout level. Volume confirmation needed. Relative strength improving.

0 · Reply

Market Cap	179.99M
Revenue (ttm)	335.71M
Net Income (ttm)	-35.89M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-10.69%
Debt to Equity Ratio	0.00

Volume	127,400
Avg Vol	175,190
Day's Range	N/A - N/A
Shares Out	27.15M
Stochastic %K	41%
Beta	1.76
Analysts	Sell
Price Target	$13.00